358 related articles for article (PubMed ID: 21958960)
1. Humoral immunity and antibody-mediated rejection in solid organ transplantation.
Montgomery RA; Cozzi E; West LJ; Warren DS
Semin Immunol; 2011 Aug; 23(4):224-34. PubMed ID: 21958960
[TBL] [Abstract][Full Text] [Related]
2. Humoral immunity in chronic allograft rejection: puzzle pieces come together.
Thaunat O
Transpl Immunol; 2012 Mar; 26(2-3):101-6. PubMed ID: 22108536
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. Modifiers of complement activation for prevention of antibody-mediated injury to allografts.
Hughes PD; Cohney SJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):425-33. PubMed ID: 21681097
[TBL] [Abstract][Full Text] [Related]
6. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
Pascual MA; Crespo M; Tolkoff-Rubin N
Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
[TBL] [Abstract][Full Text] [Related]
7. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
8. Alloantibodies and outcomes of deceased donor kidney allografts.
Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
[TBL] [Abstract][Full Text] [Related]
9. Subclinical Antibody-Mediated Rejection.
Arias M; Serón D; Herrero I; Rush DN; Wiebe C; Nickerson PW; Ussetti P; Rodrigo E; de Cos MA
Transplantation; 2017 Jun; 101(6S Suppl 1):S1-S18. PubMed ID: 28538291
[No Abstract] [Full Text] [Related]
10. Destructive and protective effects of antibody on transplants in humans: practical and theoretical considerations.
Baldwin WM; Paul LC; Claas FH; Daha MR
Prog Clin Biol Res; 1986; 224():41-67. PubMed ID: 3540995
[TBL] [Abstract][Full Text] [Related]
11. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
12. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
Pescovitz MD
Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
Gupta A; Sinnott P
Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
[TBL] [Abstract][Full Text] [Related]
14. Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective.
Biglarnia AR; Ekdahl KN; Nilsson B
Adv Exp Med Biol; 2015; 865():211-33. PubMed ID: 26306452
[TBL] [Abstract][Full Text] [Related]
15. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
16. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
[TBL] [Abstract][Full Text] [Related]
17. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
18. [Antibody-mediated acute rejection].
Lefaucheur C; Nochy D; Glotz D
Nephrol Ther; 2008 Oct; 4 Suppl 3():S188-91. PubMed ID: 19000885
[TBL] [Abstract][Full Text] [Related]
19. Significance of donor-specific antibodies in acute rejection.
Feucht HE
Transplant Proc; 2005 Nov; 37(9):3693-4. PubMed ID: 16386508
[TBL] [Abstract][Full Text] [Related]
20. Phenotypes of antibody-mediated rejection in organ transplants.
Mengel M; Husain S; Hidalgo L; Sis B
Transpl Int; 2012 Jun; 25(6):611-22. PubMed ID: 22533649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
